Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Mar;241(3):e70019.
doi: 10.1111/apha.70019.

Proinflammatory cytokines and neuropeptides in psoriasis, depression, and anxiety

Emily L Keenan  1 , Richard D Granstein  1
Affiliations
Review

Proinflammatory cytokines and neuropeptides in psoriasis, depression, and anxiety

Emily L Keenan et al. Acta Physiol (Oxf). 2025 Mar.

Abstract

Psoriasis vulgaris has established associations with psychiatric conditions such as depression, anxiety, and chronic stress. This review aims to evaluate current theories and evidence regarding the role of proinflammatory cytokines and neuropeptides in connecting systemic inflammation, psychological stress, and inflammatory skin diseases, namely psoriasis. A literature review was conducted to analyze studies that explore the connections between psoriasis, psychiatric conditions, and biological mediators, including inflammatory cytokines [interferon (IFN)-γ, interleukin (IL)-1, IL-2, IL-6, IL-12, tumor necrosis factor (TNF)-α, IL-22, IL-17], neuropeptides [calcitonin gene-related peptide (CGRP), substance P (SP), and vasoactive intestinal peptide (VIP)], as well as the hypothalamic-pituitary-adrenal (HPA) axis. Existing literature indicates that psychiatric state can influence cutaneous conditions through immune, neural, and endocrine mediators. The elevated rates of anxiety and depression observed in psoriasis patients are likely due to both the inflammatory process itself and the chronic stress associated with disease management, highlighting the importance of managing stress, and addressing mental health to improve clinical outcomes. While the literature suggests proinflammatory cytokines and neuropeptides may be key links between systemic inflammation, psoriasis, and psychiatric comorbidities, further research is necessary to continue to elucidate physiological mechanisms and explore the potential for new treatment modalities.

Keywords: calcitonin gene‐related peptide (CGRP); chronic psychological stress; inflammation in anxiety and depression; proinflammatory cytokines and neuropeptides; psoriasis pathogenesis; psychiatric comorbidities in psoriasis.

PubMed Disclaimer

References

REFERENCES

    1. Rieder E, Tausk F. Psoriasis, a model of dermatologic psychosomatic disease: psychiatric implications and treatments. Int J Dermatol. 2012;51(1):12‐26.
    1. Gondo G, Domire J, Merola JF, Gottlieb A, Bell S. Understanding the impact of psoriatic disease on mental health: results from the National Psoriasis Foundation annual survey. J Invest Dermatol. 2020;140(7):S61.
    1. Daglioglu EBY, Cadirci D, Aksoy M. Effects of disease severity on quality of life in patients with psoriasis. Dermatol Ther. 2020;33(6):e14422.
    1. Weiss SC, Kimball AB, Liewehr DJ, Blauvelt A, Turner ML, Emanuel EJ. Quantifying the harmful effect of psoriasis on health‐related quality of life. J Am Acad Dermatol. 2002;47(4):512‐518.
    1. Krueger G, Koo J, Lebwohl M, Menter A, Stern RS, Rolstad T. The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient‐membership survey. Arch Dermatol. 2001;137(3):280‐284.